FIELD: medicine.
SUBSTANCE: invention refers to treating a neurodegenerative disease. Disclosed is the use of targeted non-invasive transplantation of live mitochondria into the brain by intranasal administration for treating a neurodegenerative disease characterized by mitochondrial dysfunction.
EFFECT: invention provides effective delivery of mitochondria into the brain.
1 cl, 22 dwg, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF PROTEIN YB-1 AND ITS FRAGMENTS FOR PRODUCTION OF MEDICATIONS IN TREATMENT OF ALZHEIMER'S DISEASE | 2013 |
|
RU2561050C2 |
| 4-(3-((2-ADAMANTYL)AMINO)-3-OXOPROP-1-EN-1-YL)-N-HYDROXYBENZAMIDE - A NEW DRUG FOR THE TREATMENT OF ALZHEIMER'S DISEASE | 2022 |
|
RU2783995C1 |
| PEPTIDE HAVING CURATIVE EFFECT AGAINST ALZHEIMER DISEASE | 2014 |
|
RU2558242C1 |
| USE OF A DERIVATIVE OF CINNAMIC ACID IN ALZHEIMER'S DISEASE AS A CEREBROPROTECTIVE AGENT THAT REGULATES THE FUNCTION OF VDAC1 | 2022 |
|
RU2810301C2 |
| PEPTIDE WITH TREATMENT ACTION AGAINST ALZHEIMER'S DISEASE | 2016 |
|
RU2626972C2 |
| PEPTIDE HAVING LYNX1 PROTEIN ACTIVITY (EMBODIMENTS), PHARMACEUTICAL COMPOSITION FOR TREATING ANXIETY DISORDERS AND DEPRESSION OR CORRECTION OF COGNITIVE DISORDERS IN NEURODEGENERATIVE DISEASES, CONTAINING SAID PEPTIDE, AND METHOD OF TREATING AND CORRECTING SAID DISORDERS | 2020 |
|
RU2734649C1 |
| PEPTIDE HAVING THERAPEUTIC EFFECT AGAINST ALZHEIMER'S DISEASE | 2018 |
|
RU2677296C2 |
| METHOD FOR PREVENTING THE DEVELOPMENT OF MYOCARDIAL INFARCTION IN MICE WITH MELANOMA THAT DEVELOPED AGAINST THE BACKGROUND OF CHRONIC NEUROGENIC PAIN | 2022 |
|
RU2786322C1 |
| METHOD OF THE MELANOMA TUMOR NODES FORMATION IN THE BODY OF EXPERIMENTAL ANIMALS | 2022 |
|
RU2796892C1 |
| METHOD OF FORMATION OF TUMOR GROWTH IN LUNGS OF EXPERIMENTAL ANIMALS | 2023 |
|
RU2810431C1 |
